Spencer Riley K, Elhage Kareem G, Jin Joy Q, Davis Mitchell S, Hakimi Marwa, Bhutani Tina, Chang Howard, Liao Wilson
Department of Dermatology, University of California San Francisco, Floor 04, Room N426, 2340 Sutter Street, Box 0808, San Francisco, CA, 94115, USA.
Midwestern University, Arizona College of Osteopathic Medicine, Glendale, AZ, USA.
Dermatol Ther (Heidelb). 2023 Apr;13(4):857-866. doi: 10.1007/s13555-023-00907-1. Epub 2023 Mar 11.
Psoriasis vulgaris is a systemic, chronic inflammatory disease affecting 2-3% of the population. Recent advances in the understanding of the pathophysiology of psoriatic disease have facilitated the development of novel therapeutic options with improved safety and efficacy. This article is coauthored by a patient with a lifelong history of psoriasis who experienced multiple treatment failures. He details his diagnosis and treatment experiences, as well as the physical, mental, and social ramifications of his skin condition. He then goes on to elaborate how evolutions in the treatment of psoriatic disease have impacted his life. This case is then discussed from the perspective of a dermatologist specializing in inflammatory skin disorders. We highlight the clinical features of psoriasis, its medical and psychosocial comorbidities, and the current landscape of psoriatic disease treatments.
寻常型银屑病是一种影响2%至3%人口的全身性慢性炎症性疾病。对银屑病疾病病理生理学认识的最新进展推动了具有更高安全性和疗效的新型治疗方案的开发。本文由一位患有终身银屑病病史且经历过多次治疗失败的患者共同撰写。他详细讲述了自己的诊断和治疗经历，以及皮肤状况对其身体、心理和社会方面的影响。然后，他阐述了银屑病治疗的进展如何影响了他的生活。接着，一位专门研究炎症性皮肤病的皮肤科医生从专业角度对该病例进行了讨论。我们重点介绍了银屑病的临床特征、其医学和心理社会合并症，以及银屑病疾病治疗的当前情况。
